We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Canada Blasts Eli Lilly’s Claims In NAFTA Patent Dispute
Canada Blasts Eli Lilly’s Claims In NAFTA Patent Dispute
Canada has fired back in its dispute with Eli Lilly over court rulings that invalidated patents covering two of the drugmaker’s therapies, charging that Lilly has grossly mischaracterized the country’s patent policies.